Last Update 07 Jul 26
Fair value Increased 13%JEN: Mixed Broker Views And P/E Assumptions Will Shape Fair Value
The analyst price target for Jenoptik has increased from €38.31 to €43.44. Analysts attribute this change to updated assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E, as well as recent mixed broker commentary, which includes a higher €44 target from one firm and a downgrade from another.
Analyst Commentary
Recent research on Jenoptik reflects a split view, with some analysts revising fair value assumptions higher and others turning more cautious. For you as an investor, the key themes center on whether current execution can support higher valuation multiples and how reliably the company can deliver on growth expectations.
Bullish Takeaways
- Bullish analysts see support for a higher fair value for Jenoptik, with a price target of €44 indicating confidence in the company’s long term earnings power.
- They appear comfortable with current P/E assumptions, suggesting that Jenoptik’s earnings profile can justify a richer valuation compared with earlier estimates.
- The higher target implies optimism that Jenoptik can execute on its revenue growth plans and sustain margins close to the levels used in updated models.
- Supportive commentary points to a view that recent data points and company updates are consistent with the long term investment case rather than a reason to reduce valuation assumptions.
Bearish Takeaways
- Bearish analysts have downgraded their stance on Jenoptik, signaling concern that execution or growth may fall short of earlier expectations.
- The downgrade suggests a view that current valuation already prices in much of the upside from existing business plans, leaving less room for error.
- Cautious commentary reflects worries that assumptions for revenue growth or profit margins embedded in some models could be too optimistic.
- There is also an implied risk that, if Jenoptik does not meet updated targets, investors might reassess the appropriate P/E multiple and fair value used for the stock.
What’s in the News for Jenoptik
- Jenoptik confirmed earnings guidance for fiscal 2026, stating it continues to expect revenue to be up in the single-digit percentage range compared with the prior year. (Source: Company guidance)
Valuation Changes for Jenoptik
- Fair Value: The updated fair value estimate has risen from €38.31 to €43.44, a gain of around 13% in the modelled target level.
- Discount Rate: The discount rate has fallen slightly from 7.24% to 7.16%, implying a modestly lower required return in the latest assumptions.
- Revenue Growth: Modelled revenue growth has increased from 7.86% to 8.67%, indicating a slightly stronger expected top line trajectory for Jenoptik.
- Net Profit Margin: The assumed net profit margin has moved up from 10.59% to 11.50%, reflecting a higher margin profile in the updated forecasts.
- Future P/E: The future P/E assumption has edged higher from 19.77x to 20.12x, suggesting a marginally richer valuation multiple in the current model.
Key Takeaways
- Momentum in semiconductor, biophotonics, and mobility segments, combined with global expansion, diversifies revenue and positions for sustained long-term growth.
- Strategic shift to higher-margin photonic solutions and disciplined cost management are driving improved margins and elevated earnings quality.
- Exposure to volatile end-markets, margin compression, and tariff risks threaten revenue predictability, profitability, and delay sustainable recovery amid ongoing demand uncertainty.
Catalysts
About Jenoptik- Provides advanced photonic solutions and smart mobility solutions in Germany and internationally.
- Jenoptik is positioned to benefit from increasing global investment in semiconductor manufacturing (spurred by AI, automotive, and IoT demand), as order intake in its semi segment showed significant quarter-on-quarter improvement and customers are signaling readiness for capacity ramp, which, if sustained, would drive revenue and margin recovery over the next 12-18 months.
- Strong momentum in the Biophotonics segment, with robust order intake and double-digit revenue growth across key areas like dental, ophthalmology, and life science, demonstrates exposure to rising automation and digitalization needs in healthcare and diagnostics, supporting both top-line expansion and higher EBITDA margins.
- Jenoptik's Smart Mobility Solutions business is experiencing rapid growth, especially in the U.S. and Middle East, reflecting rising investment in smart infrastructure and intelligent traffic management; this contributes to diversified revenue streams and higher overall growth potential.
- Ongoing portfolio shift towards higher-margin, software-enabled photonic solutions, combined with disciplined cost and cash management (evidenced by a material increase in cash conversion rate and reduced headcount), is likely to support margin expansion and enhance earnings quality over the medium term.
- Expansion of production and customer presence in North America and Asia-as evidenced by growing business in U.S. markets and localized production capabilities-reduces concentration risk, improves resilience amid geopolitical volatility, and positions Jenoptik to capture more growth from global photonics adoption, supporting organic revenue growth longer-term.
Jenoptik Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Jenoptik's revenue will grow by 8.7% annually over the next 3 years.
- Analysts assume that profit margins will increase from 7.3% today to 11.5% in 3 years time.
- Analysts expect earnings to reach €154.0 million (and earnings per share of €2.65) by about July 2029, up from €76.4 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting €182.1 million in earnings, and the most bearish expecting €138.5 million.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 20.3x on those 2029 earnings, down from 32.7x today. This future PE is lower than the current PE for the GB Electronic industry at 33.4x.
- Analysts expect the number of shares outstanding to grow by 0.41% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 7.16%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Ongoing elevated market uncertainty and fragmented demand patterns across key segments (especially in semiconductors and metrology) create significant volatility in quarterly revenues, reducing visibility and predictability for long-term revenue growth.
- Persistent weakness in the semiconductor (Semi) division, which remains a major business driver and is exposed to supply chain disruptions, inventory cycles, and mixed customer messages, may continue to pressure both top-line revenue and margin recovery.
- Margin compression is evident, with year-on-year declines in gross margin (down 250 bps) and EBITDA margin (down 300 bps), primarily due to negative product mix effects, lower fixed-cost absorption, wage inflation, and tariff impacts, which are expected to persist and could further erode net margins if demand does not sustainably recover.
- Tariff uncertainty, especially regarding business with the U.S., poses both direct costs (estimated at 50 bps for the partial year, potentially higher if full-year impact materializes) and longer-term risks around competitive positioning, potentially undermining both revenue and profitability if Jenoptik faces cost disadvantages versus localized competitors.
- High reliance on cyclical and volatile end-markets (e.g., semiconductors, automotive, OEMs) and the lack of clear evidence for a sustained demand recovery expose Jenoptik to ongoing revenue swings and increase the risk of extended periods of underutilization, which may delay earnings recovery and strain free cash flow.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of €43.44 for Jenoptik based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €55.0, and the most bearish reporting a price target of just €29.5.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €1.3 billion, earnings will come to €154.0 million, and it would be trading on a PE ratio of 20.3x, assuming you use a discount rate of 7.2%.
- Given the current share price of €43.68, the analyst price target of €43.44 is 0.6% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Jenoptik?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.